{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:41:56Z","timestamp":1789774916086,"version":"4.0.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Diagnosing Alport syndrome can be particularly challenging when targeted sequencing methods, such as panel-based next-generation sequencing (NGS), fail to identify pathogenic variants, especially deep intronic mutations. The syndrome is caused by mutations in type IV collagen genes (<jats:italic>COL4A3<\/jats:italic>, <jats:italic>COL4A4<\/jats:italic>, or <jats:italic>COL4A5<\/jats:italic>), with X-linked Alport syndrome (XLAS) accounting for approximately 80% of cases. Here, we report the case of a 4-year-old boy who presented with persistent microscopic hematuria detected during routine urinalysis. Although renal ultrasonography showed mild bilateral medullary nephrocalcinosis, no proteinuria was observed. His mother had been previously diagnosed with Alport syndrome by renal biopsy, but prior targeted sequencing failed to identify any disease-causing variants. To avoid an invasive renal biopsy in this pediatric patient, we directly performed whole genome sequencing (WGS), identifying a novel deep intronic hemizygous variant in the <jats:italic>COL4A5<\/jats:italic> gene (c.2395\u2009+\u20092723T\u2009&amp;gt;\u2009G). This variant, classified as a variant of uncertain significance (VUS) according to ACMG-AMP guidelines, was confirmed by Sanger sequencing to be hemizygous in the patient and heterozygous in his mother. The patient currently maintains normal renal function, vision, and hearing, with only microscopic hematuria persisting. This case highlights the diagnostic challenges posed by deep intronic variants in XLAS and demonstrates the clinical utility of WGS in cases where conventional genetic testing is inconclusive. Early genetic diagnosis facilitated timely intervention without requiring invasive procedures, emphasizing the growing role of comprehensive genomic sequencing in uncovering elusive genetic variants in clinically suspected Alport syndrome.<\/jats:p>","DOI":"10.3389\/fped.2025.1639471","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T04:12:29Z","timestamp":1754539949000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: Whole genome sequencing identifies a novel deep intronic COL4A5 variant of uncertain significance in X-linked Alport syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Hoon Seok","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myungshin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Soon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonhee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0002-9343(81)90571-4","article-title":"Alport\u2019s syndrome. A report of 58 cases and a review of the literature","volume":"70","author":"Gubler","year":"1981","journal-title":"Am J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2015.12.014","article-title":"US renal data system 2015 annual data report: epidemiology of kidney disease in the United States","volume":"67","author":"Saran","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/bmj.1.3454.504","article-title":"Hereditary familial congenital haemorrhagic nephritis","volume":"1","author":"Alport","year":"1927","journal-title":"Br Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/bf00849246","article-title":"Familial glomerulonephritis","volume":"1","author":"Rambausek","year":"1987","journal-title":"Pediatr Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/bf00849247","article-title":"Variants of Alport\u2019s syndrome","volume":"1","author":"Gr\u00fcnfeld","year":"1987","journal-title":"Pediatr Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00467-018-3985-4","article-title":"Expert consensus guidelines for the genetic diagnosis of Alport syndrome","volume":"34","author":"Savige","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2215\/cjn.04230321","article-title":"Guidelines for genetic testing and management of Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/ndt\/gfae265","article-title":"Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN","volume":"40","author":"Torra","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.2215\/cjn.04140414","article-title":"X-linked Alport syndrome caused by splicing mutations in COL4A5","volume":"9","author":"Nozu","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"18097","DOI":"10.1038\/s41598-021-97414-0","article-title":"mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1009188","DOI":"10.3389\/fped.2022.1009188","article-title":"A deep intronic splice variant of the COL4A5 gene in a Chinese family with X-linked Alport syndrome","volume":"10","author":"Qian","year":"2022","journal-title":"Front Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.kint.2023.05.006","article-title":"A wave of deep intronic mutations in X-linked Alport syndrome","volume":"104","author":"Boisson","year":"2023","journal-title":"Kidney Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/ki.2014.326","article-title":"Pathology vs. Molecular genetics: (re)defining the spectrum of Alport syndrome","volume":"86","author":"Miner","year":"2014","journal-title":"Kidney Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ekir.2018.01.008","article-title":"Genotype and outcome after kidney transplantation in Alport syndrome","volume":"3","author":"Gillion","year":"2018","journal-title":"Kidney Int Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ki.1985.63","article-title":"Genetic heterogeneity of Alport syndrome","volume":"27","author":"Feingold","year":"1985","journal-title":"Kidney Int"},{"key":"B16","first-page":"777","article-title":"Inherited glomerular diseases","volume-title":"Pediatric Nephrology","author":"Rheault","year":"2015"},{"key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of digenic inheritance in Alport syndrome","volume":"52","author":"Mencarelli","year":"2015","journal-title":"J Med Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s00439-002-0830-3","article-title":"Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome","volume":"111","author":"King","year":"2002","journal-title":"Hum Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","article-title":"Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria","volume":"29","author":"Savige","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1432-1033.1987.tb13450.x","article-title":"Completion of the amino acid sequence of the alpha 1 chain of human basement membrane collagen (type IV) reveals 21 non-triplet interruptions located within the collagenous domain","volume":"168","author":"Brazel","year":"1987","journal-title":"Eur J Biochem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.2349482","article-title":"Identification of mutations in the COL4A5 collagen gene in Alport syndrome","volume":"248","author":"Barker","year":"1990","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nrc1094","article-title":"Basement membranes: structure, assembly and role in tumour angiogenesis","volume":"3","author":"Kalluri","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/archotol.131.11.1007","article-title":"Distribution of type IV collagen in the cochlea in Alport syndrome","volume":"131","author":"Zehnder","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2215\/cjn.02190312","article-title":"Outcomes of male patients with Alport syndrome undergoing renal replacement therapy","volume":"7","author":"Temme","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/asn.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1639471\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T04:12:30Z","timestamp":1754539950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1639471\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":26,"alternative-id":["10.3389\/fped.2025.1639471"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1639471","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"article-number":"1639471"}}